GILD vs RMTI · P/E 18, rev $7.80B vs rev $35.1M
Gilead Sciences Inc (GILD) versus Rockwell Medical Inc (RMTI) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Rockwell Medical Inc (RMTI) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported RMTI revenue for 2026-06-30 was $35.1M. Net income was -$2.8M. RMTI currently screens at market cap $25.7M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. RMTI currently screens at market cap $25.7M.
Not investment advice. Open the GILD and RMTI stock pages for the full models.
Not investment advice.